At IgniteData, we’re rethinking how clinical trials handle one of their most critical resources: structured data. Every piece of information collected from patients is a gift, and our mission is to ensure it is used efficiently, accurately, and meaningfully to accelerate medical research.
Over the past year, our Archer platform has transformed the way structured data flows in clinical trials. Initially focused on oncology studies, Archer now supports multiple therapeutic areas across sites in the U.S., Canada and the U.K., helping sponsors and research teams enhance operations while maintaining the highest data quality.
We explore how structured data is shaping the future of research, improving efficiency, accuracy, and regulatory confidence for trial sponsors and sites.
Learn more about IgniteData’s mission here.
The Power of Structured Data in Clinical Trials
Structured data is the backbone of efficient, high-quality trials. When vitals, lab results, and medication records flow directly from the electronic health record (EHR) via FHIR standards, sites eliminate redundant data entry and sponsors gain standardized, regulator-ready datasets.
The benefits of structured data include:
- Efficiency – streamlined data capture accelerates study timelines.
- Accuracy – consistent formats reduce variability and errors.
- Regulatory confidence – traceable data supports faster, more reliable safety and efficacy reviews.
By building on U.S. Core Data for Interoperability (USCDI) standards, Archer ensures scalability across therapeutic areas and trial stages.
Adapting to Clinical Workflows and Expanding Data Capabilities
Archer began with the fundamentals—labs and vitals—but its scope has quickly expanded. Today, the platform pulls past medical history directly from EHR problem lists and supports adverse event reporting in investigator-led studies. Next, automation will capture medications and procedures, removing repetitive tasks for clinical staff while ensuring higher data quality.
Clinical workflows differ across sites. Some rely on EHR modules for medications or adverse events, while others record in clinical notes. Archer adapts to these differences, automating where possible and allowing manual entry when needed.
As Dr. Jose Galvez, Chief Medical Information Officer at IgniteData, emphasizes:
“Patients give us a gift every time they volunteer for clinical studies. We have one opportunity to get it right.”
By reducing administrative burden and respecting site-specific workflows, Archer helps teams focus on what matters most: patient care and high-quality research.
Looking Ahead: Unstructured Data and Patient-Centered Innovation
Not all valuable information exists in structured form. Radiology reports, lab notes, and other unstructured data hold crucial insights. By leveraging AI models and therapeutic-area-specific ontologies, IgniteData is developing ways to reliably extract this information while maintaining data provenance and regulatory trust.
Ultimately, what drives IgniteData is the mission behind the data. Clinical trial participants make sacrifices—some minor, some significant—to advance medical research. Every lab draw, vital measurement, or procedural note is a gift, and our goal is to ensure it is fully realized.
Explore how Archer supports clinical trials across therapeutic areas.
Are you ready to see how structured data in clinical trials can transform your research outcomes?
Contact IgniteData today to learn how Archer can accelerate your trial timelines, improve data quality, and support regulatory readiness.